BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8649654)

  • 1. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO; Alaupovic P
    Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Composition and distribution of lipid and apolipoprotein in plasma lipoproteins of endogenous hypertriglyceridemia].
    Zhang L; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):117-21. PubMed ID: 1452137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
    Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J
    Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
    Sehayek E; Eisenberg S
    J Biol Chem; 1991 Sep; 266(27):18259-67. PubMed ID: 1917954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in levels and interrelations of plasma apolipoproteins induced by diet.
    Schonfeld G; Weidman SW; Witztum JL; Bowen RM
    Metabolism; 1976 Mar; 25(3):261-75. PubMed ID: 175240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.
    Berman M; Hall M; Levy RI; Eisenberg S; Bilheimer DW; Phair RD; Goebel RH
    J Lipid Res; 1978 Jan; 19(1):38-56. PubMed ID: 202659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoproteins in human pregnancy.
    Hillman L; Schonfeld G; Miller JP; Wulff G
    Metabolism; 1975 Aug; 24(8):943-52. PubMed ID: 167266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the composition of plasma lipoproteins in the chronic uremic rat.
    Barry LE; Tan MH
    Atherosclerosis; 1990 Dec; 85(2-3):139-50. PubMed ID: 2102077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.
    Liu G; Zhang B; Hu Y; Rood J; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Furtado JD; Sun Q
    Environ Health; 2020 Jan; 19(1):5. PubMed ID: 31931806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoproteins in experimental nephrosis: plasma levels and composition.
    Marsh JB; Sparks CE
    Metabolism; 1979 Oct; 28(10):1040-5. PubMed ID: 226831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis.
    Rapoport J; Aviram M; Chaimovitz C; Brook JG
    N Engl J Med; 1978 Dec; 299(24):1326-9. PubMed ID: 213715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.
    Desai NK; Ooi EM; Mitchell PD; Furtado J; Sacks FM
    Atherosclerosis; 2015 Aug; 241(2):326-33. PubMed ID: 26071654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipoproteinemia in diabetic renal failure.
    Attman PO; Nyberg G; William-Olsson T; Knight-Gibson C; Alaupovic P
    Kidney Int; 1992 Dec; 42(6):1381-9. PubMed ID: 1474769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid transport in the avian species. Part I. Isolation and characterization of apolipoproteins and major lipoprotein density classes of male turkey serum.
    Kelley JL; Alaupovic P
    Atherosclerosis; 1976; 24(1-2):155-75. PubMed ID: 182183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoproteins and apolipoproteins in the preruminant calf, Bos spp: density distribution, physicochemical properties, and the in vivo evaluation of the contribution of the liver to lipoprotein homeostasis.
    Bauchart D; Durand D; Laplaud PM; Forgez P; Goulinet S; Chapman MJ
    J Lipid Res; 1989 Oct; 30(10):1499-514. PubMed ID: 2614254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells.
    Dashti N; Smith EA; Alaupovic P
    J Lipid Res; 1990 Jan; 31(1):113-23. PubMed ID: 2313196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes.
    Sentí M; Nogués X; Pedro-Botet J; Rubiés-Prat J; Vidal-Barraquer F
    Circulation; 1992 Jan; 85(1):30-6. PubMed ID: 1728461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.